AstraZeneca trial, illness link 'unlikely'

By Manojna Maddipatla
Updated September 17 2020 - 3:51am, first published 3:48am
A side effect in an AstraZeneca trial participant was unlikely due to the vaccine, researchers say.
A side effect in an AstraZeneca trial participant was unlikely due to the vaccine, researchers say.

The adverse events that led to a pause in trials evaluating AstraZeneca Plc's COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Cessnock news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.